Company / Free Cash Flow
Zoetis Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$2.3B
FY2025
5-year range
$1.3B / $2.3B
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#10 of 194
Health Care
What the data says
Among 194 Health Care companies, Zoetis is in the top 5% for free cash flow. Free Cash Flow has fluctuated over the past 10 years, ranging from $440M in FY2017 to $2.3B in FY2024.
Based on SEC 10-K filings.
$2.3B in FY2025 with a 5-year CAGR of +9.5%. Top quartile in the Health Care sector.
Improved from $1.7B to $2.3B over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +10.9%
- 5-Year CAGR
- +9.5%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 194This company $2.3B Sector average $470.6M
▼
+385.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +9.5%, indicating consistent growth.
- In FY2025, free cash flow decreased 0.7% year-over-year.
- Ranks #10 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3B | -0.7% |
| FY2024 | $2.3B | +32.4% |
| FY2023 | $1.7B | +3.8% |
| FY2022 | $1.7B | +25.3% |
| FY2021 | $1.3B | -8.1% |
| FY2020 | $1.5B | +8.8% |
| FY2019 | $1.3B | -8.1% |
| FY2018 | $1.5B | +230.0% |
| FY2017 | $440.0M | -1.3% |
| FY2016 | $446.0M | -10.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026